QUALITY OF LIFE IN PATIENTS WITH THYROID EYE DISEASE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

BAHMANI KASHKOULI M.; PAKDEL FARZAD; ASTARAKI A.; HASHEMI MASIH; HONARBAKHSH Y.; MIRARMANDEHI B.; JAM SARA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Journal of Ophthalmic and Vision Research Year:2009 | Volume:4 | Issue:3 Page(s): 164-168

Download Full-Text

View:

283

Download:

107

Cites:

Information Journal Paper

Title

QUALITY OF LIFE IN PATIENTS WITH THYROID EYE DISEASE

Author(s)

Keywords

GRAVES OPHTHALMOPATHY

QUALITY OF LIFE

Abstract

Purpose: To evaluate QUALITY OF LIFE (QOL) before and after corticosteroid therapy for thyroid eye disease (TED) and to determine the impact of the disease on QOL.Methods: A modified TED-QOL questionnaire was completed by consecutive patients before and at least 6 months after steroid therapy. All patients were clinically and biochemically euthyroid during the course of the study. QOL was assessed in subscales of visual function, psychosocial, and educational/counseling; TED was classified by severity score (NOSPECS) and Mourits’ clinical activity score.Results: Overall, 61 patients including 18 (29.5%) male and 43 (70.5%) female subjects with mean age of 37.3±13.7 (range, 18-33) years were enrolled. Mean duration of thyroid dysfunction and TED were 40.1±44.8 and 26.5±38.2 months, respectively. Mean disease severity and activity significantly decreased, and visual and psychosocial function scores significantly improved following corticosteroid therapy for TED. Psychosocial score was significantly worse than visual function score before but not after steroid treatment. Linear regression analysis and Spearman correlation test showed no significant correlation between duration of thyroid dysfunction, duration of TED, disease severity and activity on one hand, and QOL scores on the other hand, before or after treatment.Conclusion: TED seems to adversely affect psychosocial activity more than visual function. Corticosteroid therapy significantly improves QOL. No significant correlation seems to exist between QOL scores and the severity or activity of TED.

Cites

No record.

References

Cite

APA: Copy

BAHMANI KASHKOULI, M., PAKDEL, FARZAD, ASTARAKI, A., HASHEMI, MASIH, HONARBAKHSH, Y., MIRARMANDEHI, B., & JAM, SARA. (2009). QUALITY OF LIFE IN PATIENTS WITH THYROID EYE DISEASE. JOURNAL OF OPHTHALMIC AND VISION RESEARCH, 4(3), 164-168. SID. https://sid.ir/paper/311375/en

Vancouver: Copy

BAHMANI KASHKOULI M., PAKDEL FARZAD, ASTARAKI A., HASHEMI MASIH, HONARBAKHSH Y., MIRARMANDEHI B., JAM SARA. QUALITY OF LIFE IN PATIENTS WITH THYROID EYE DISEASE. JOURNAL OF OPHTHALMIC AND VISION RESEARCH[Internet]. 2009;4(3):164-168. Available from: https://sid.ir/paper/311375/en

IEEE: Copy

M. BAHMANI KASHKOULI, FARZAD PAKDEL, A. ASTARAKI, MASIH HASHEMI, Y. HONARBAKHSH, B. MIRARMANDEHI, and SARA JAM, “QUALITY OF LIFE IN PATIENTS WITH THYROID EYE DISEASE,” JOURNAL OF OPHTHALMIC AND VISION RESEARCH, vol. 4, no. 3, pp. 164–168, 2009, [Online]. Available: https://sid.ir/paper/311375/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops